cagrisema cagrilintide semaglutide phase 3 results 2024 2025 obesity drug: what the data shows Novo Nordisk presents new Phase
Description
Inspect the injection site to ensure it is clear of bruising, swelling, irritation or hardness
doi: 10.1111/acel.12927
Pooling the data allowed for a broader range of serum levels, more data, and thus improved statistical power
doi: 10.3181/00379727-100-24576
